Abstract
The Centers for Disease Control and Prevention, or CDC, has a long history of providing traceability in clinical laboratory medicine. Early work was to develop reference methods for important clinical analytes. When the National Cholesterol Education Program issued recommendations for physicians and clinical laboratories for measurement of lipids and lipoproteins, CDC formed the Cholesterol Reference Method Laboratory Network (CRMLN) to provide manufacturers with access to the accuracy bases. The CRMLN assists manufacturers with calibration of diagnostic products to ensure traceability to higher-order technology. A certification program for manufacturers assures the clinical laboratory community that these products are accurate and precise. The CRMLN model for traceability has been applied to other networks, notably the National Glycohemoglobin Standardization Program.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
